Zobrazeno 1 - 10
of 449
pro vyhledávání: '"Genes ErbB"'
Autor:
Xing L; Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, China., Wu G; Cancer Center, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Wang L; Department of Radiation Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China., Li J; Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Clinical College of Fujian Medical University, Fuzhou, China., Wang J; Department of Radiation Oncology, Zhengzhou University Cancer Hospital, Zhengzhou, China., Yuan Z; Department of Radiation Oncology, CyberKnife Center, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, China., Chen M; Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China., Xu Y; Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China., Fu X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Lu Y; Department of Thoracic Oncology, Huaxi Hospital, Sichuan University, Chengdu, China., Han C; Department of Thoracic Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Xia T; Department of Radiation Oncology, Air Force General Hospital, Beijing, China., Xie C; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China., Li G; Department of Radiation Oncology, First Hospital of China Medical University, Shenyang, China., Ma S; Department of Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China., Lu B; Department of Radiation Oncology, Guizhou Cancer Hospital, Guiyang, China., Lin Q; Department of Radiation Oncology, First Affiliated Hospital of Xiamen University, Xiamen, China., Zhu G; Department of Radiation Oncology, Beijing Cancer Hospital, Beijing, China., Qu B; Department of Radiation Oncology, PLA General Hospital, Beijing, China., Zhu W; Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, China., Yu J; Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, China. Electronic address: sdyujinming@126.com.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Apr 01; Vol. 109 (5), pp. 1349-1358. Date of Electronic Publication: 2020 Nov 19.
Autor:
Noorani I; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK. in1@sanger.ac.uk.; Department of Neurosurgery, Addenbrookes Hospital, University of Cambridge, Hills Road, Cambridge, CB2 0QQ, UK. in1@sanger.ac.uk., de la Rosa J; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Choi YH; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.; Department of New Biology, DGIST, 333, Techno Jungang Daero, Hyeonpung-Myeon, Dalseong-Gun, Daegu, 42988, South Korea., Strong A; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Ponstingl H; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Vijayabaskar MS; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Lee J; Department of New Biology, DGIST, 333, Techno Jungang Daero, Hyeonpung-Myeon, Dalseong-Gun, Daegu, 42988, South Korea., Lee E; Department of New Biology, DGIST, 333, Techno Jungang Daero, Hyeonpung-Myeon, Dalseong-Gun, Daegu, 42988, South Korea., Richard-Londt A; Division of Neuropathology and Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, Mailbox 126, London, WC1N 3BG, UK., Friedrich M; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.; Department of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany., Furlanetto F; Department of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany., Fuente R; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Banerjee R; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Yang F; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Law F; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Watts C; Department of Neurosurgery, Addenbrookes Hospital, University of Cambridge, Hills Road, Cambridge, CB2 0QQ, UK.; Birmingham Brain Cancer Program, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Rad R; Department of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany., Vassiliou G; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Kim JK; Department of New Biology, DGIST, 333, Techno Jungang Daero, Hyeonpung-Myeon, Dalseong-Gun, Daegu, 42988, South Korea., Santarius T; Department of Neurosurgery, Addenbrookes Hospital, University of Cambridge, Hills Road, Cambridge, CB2 0QQ, UK., Brandner S; Division of Neuropathology and Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, Mailbox 126, London, WC1N 3BG, UK., Bradley A; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK. abradley@sanger.ac.uk.
Publikováno v:
Genome biology [Genome Biol] 2020 Jul 30; Vol. 21 (1), pp. 181. Date of Electronic Publication: 2020 Jul 30.
Autor:
Matsuda K; Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan., Hirayama D; Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan., Hino N; Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan., Kuno S; Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan., Sakaue-Sawano A; Laboratory for Cell Function Dynamics, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan., Miyawaki A; Laboratory for Cell Function Dynamics, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan., Matsuda M; Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.; Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.; Institute for Integrated Cell-Material Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan., Terai K; Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
Publikováno v:
Journal of cell science [J Cell Sci] 2023 Aug 15; Vol. 136 (16). Date of Electronic Publication: 2023 Aug 21.
Autor:
Piha-Paul SA; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA. spihapau@mdanderson.org., Tseng C; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Tran HT; Department of Thoracic, Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gao M; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Karp DD; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Subbiah V; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Tsimberidou AM; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Kawedia JD; Pharmacy Pharmacology Research, Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, USA., Fu S; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Pant S; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yap TA; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA.; Department of Thoracic, Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morris VK; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kee BK; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Blum Murphy M; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lim J; Pharmacy Clinical Programs, Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA.; Department of Breast Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2023 Aug; Vol. 92 (2), pp. 107-118. Date of Electronic Publication: 2023 Jun 14.
Autor:
Vidal ÓJ; Servicio de Oncología Médica, Hospital Universitari i Politècnic La Fe, Valencia, España. Electronic address: juan_osc@gva.es.
Publikováno v:
Medicina clinica [Med Clin (Barc)] 2016 Apr; Vol. 146 Suppl 1, pp. 12-8.
Autor:
Artal Cortés Á; Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Zaragoza, España. Electronic address: aartalc@salud.aragon.es., Gimeno Pelegrín J; Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Zaragoza, España., Alejandro MÁ; Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Zaragoza, España.
Publikováno v:
Medicina clinica [Med Clin (Barc)] 2016 Apr; Vol. 146 Suppl 1, pp. 19-24.
Autor:
Guo L; Laboratory of Investigative Toxicology, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.; These authors contributed equally to this work., Eldridge S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; These authors contributed equally to this work., Furniss M; Laboratory of Investigative Toxicology, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Mussio J; Laboratory of Investigative Toxicology, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Davis M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
Publikováno v:
Current protocols in chemical biology [Curr Protoc Chem Biol] 2015 Sep 01; Vol. 7 (3), pp. 141-185. Date of Electronic Publication: 2015 Sep 01.
Autor:
Szmida E; Department of Genetics, Wroclaw Medical University, ul. Marcinkowskiego 1, 50-368, Wroclaw, Poland, e.szmida@gmail.com., Karpiński P, Leszczynski P, Sedziak T, Kielan W, Ostasiewicz P, Sasiadek MM
Publikováno v:
Journal of applied genetics [J Appl Genet] 2015 May; Vol. 56 (2), pp. 185-92. Date of Electronic Publication: 2014 Nov 01.
Autor:
Bredel M; Department of Radiation Oncology, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA., Kim H; Lineberger Comprehensive Cancer Center, University of Northern Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Bonner JA; Department of Radiation Oncology, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Nov 04; Vol. 23 (21). Date of Electronic Publication: 2022 Nov 04.
Autor:
van Schalkwyk MC; 1 Department of Research Oncology, King's Health Partners Integrated Cancer Centre , King's College London, London SE1 9RT, United Kingdom ., Papa SE, Jeannon JP, Guerrero Urbano T, Spicer JF, Maher J
Publikováno v:
Human gene therapy. Clinical development [Hum Gene Ther Clin Dev] 2013 Sep; Vol. 24 (3), pp. 134-42.